NeuroSense Therapeutics Ltd (NASDAQ:NRSN) currently has a daily average trading volume of 304.78K but it saw 2166107 shares traded in last market. With a market cap of 13.80M USD, the company’s current market price of $0.71 came falling about -4.32 while comparing to the previous closing price of $0.74. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.33 and as low as $0.40. In the recent trading on the day, stock has struck highest price mark of $0.6729 while lowest mark touched by it was $0.7549.
Taking a look at 20-day trading activity of NeuroSense Therapeutics Ltd (NRSN) gives us an average price of $0.7334, while its current price level is -69.57% below from 52-week high level whereas it is 77.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8472 while that of 200 days or SMA-200 reads an average of $1.1181. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.44% during that period while stretching the period over a month that increases to 13.84%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 41.16 which implies that the stock is in neutral territory.
Over the week, NRSN’s stock price is moving -12.47% down while it is -1.69% when we observe its performance for the past one month. Year-to-date it is -9.68% down and over the past year, the stock is showing a downside performance of -22.93%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.44 beaten by the consensus estimate of -0.28 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-28, for which analysts forecasted an EPS of -0.2 while estimate for next year EPS is -0.9.
Currently, NeuroSense Therapeutics Ltd’s total number of outstanding shares is 15.38M. Company’s return on equity (ROE) at -602.40%. Stock’s beta reads 1.47. Its return on asset (ROA) is -377.38% on average.
